TRIAMCINOLONE ACET 400 MG/10 ML
TRIAMCINOLONE ACET 400 MG/10 ML, a generic anti-inflammatory steroid, has an acquisition cost of $3.65, though hospitals typically charge patients significantly more than this wholesale price.
About the analyst
David Park researches procedure pricing and insurance reimbursement patterns at BillRazor Research. He specializes in cost comparison across care settings and metropolitan areas. Expertise: procedure pricing, insurance reimbursement, cost comparison.
TRIAMCINOLONE ACETONIDE 400 MG/10 ML is an injectable corticosteroid used to treat inflammatory conditions and joint pain. This generic formulation typically has lower reimbursement rates compared to brand-name alternatives, with Medicare benchmark pricing varying significantly across different administration settings.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.